Avaliação dos níveis de TAFI (inibidor da fibrinolise ativado pela trombina), do PAI-1 (inibidor do ativador do plasminogênio tipo 1) e frequência de seus polimorfismos na dislipidemia
=== Cardiovascular diseases are a public health concern with high morbidity and mortality, affected by risk factors such as diabetes mellitus, smoking, physical inactivity, hypertension, obesity and dyslipidemia. Dyslipidemia is defined as alterations in lipid metabolism that change the levels of l...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | Portuguese |
| Published: |
Universidade Federal de Minas Gerais
2013
|
| Online Access: | http://hdl.handle.net/1843/BUOS-9C6GDL |